The Fibrinolytic Efficacy and Impact on Plasma von Willlebrand Factor of Losartan Compared with Atenolol in Essential Hypertensives / 中华高血压杂志

Objectives To compare the effects of losartan and atenolol on fibrinolytic system and plasma von willebrand factor (vWF) in patients with essential hypertension. Methods Sixty patients with mild to moderate essential hypertension were randomized to receive lostartan(50 mg/d, n=30) or atenolol(50 mg/d, n=30) for 8 weeks. If the goal blood pressure(